SEPN

Septerna, Inc.
CAPPED RATING

Septerna, Inc. (SEPN) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Growth (D-). The rating has held at C for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
B-
Factor Score 2.9 / 5.0
Growth
D-
Factor Score 1.0 / 5.0
Profitability
C
Factor Score 2.3 / 5.0
Momentum
B
Factor Score 3.4 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -25.5
EV / EBITDA -21.4
Rev Growth YoY -12.2%
Gross Margin N/M
Price Return 3M -3.6%
Price Return 12M 121.5%
Catalyst Signal 0.00
Market Cap $2.0B
TTM Revenue $96.3M
Price / Sales 21.0
ROE -14.4%

Historical Factor Score Progression

Held C for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (2.9) D- (1.0) C (2.3) B (3.4) D+ (1.5) C (2.2)
2026-11-07 B- (2.9) D- (0.7) C (2.3) A- (4.0) D+ (1.5) C (2.3)
2026-10-31 B- (2.9) D- (0.7) C (2.3) A- (4.1) D+ (1.5) C (2.3)
2026-10-24 B- (2.9) D- (0.7) B (3.3) A- (3.9) D+ (1.6) C (2.5)
2026-10-17 B- (2.9) D- (0.7) B (3.3) B+ (3.8) D+ (1.5) C (2.4)
Page 1 of 4